EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Mediators of Racial Inequities in Non‐Small Cell Lung Cancer Care

Safraz A Hamid iD, Do H Lee, Jeph Herrin, James B Yu, Craig E Pollack iD, Lorraine T Dean iD, Jacquelyne J Gaddy, Carol R Oladele, Shelli L Feder, Maureen E Canavan iD, Marcella Nunez-Smith, Pamela R Soulos und 1 weitere

Cancer Medicine · 2025-03 · 14 (5)

DOI: 10.1002/cam4.70757 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 07.03.2025. Verfasst von Safraz A Hamid und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Yale School of Medicine, New Haven, Connecticut, USA. Hauptthemen laut MEDLINE: Black or African American, Carcinoma, Non-Small-Cell Lung, Healthcare Disparities, Lung Neoplasms. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMHD NIH HHS, NCATS NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Black patients with non‐small cell lung cancer (NSCLC) are more often diagnosed at a later stage and receive inadequate evaluation and treatment compared to White patients. We aimed to identify factors representing exposure to structural racism that mediate the association between race and NSCLC care.

Methods

We queried Surveillance, Epidemiology, and End Results–Medicare for non‐Hispanic Black and White patients ≥ 67 years diagnosed with NSCLC from 2013 to 2019. Our outcomes were localized diagnosis stage, receipt of stage‐appropriate evaluation, receipt of stage‐appropriate treatment, two‐year survival, and receipt of “optimal” care, an aggregate metric comprising the first three listed outcomes. We estimated indirect effects of mediators on the association between race and outcomes.

Results

Of 69,130 patients, 8.2% were Black. Medicare–Medicaid dual eligibility, a marker of individual‐level socioeconomic status (SES), accounted for the largest proportion of mediating effects for most outcomes, ranging from 13.6% ( p < 0.001) for localized diagnosis stage to 25.0% ( p < 0.001) for two‐year survival. Receipt of an influenza vaccine, a marker of health care access, had the second largest mediating effects on the associations between race and diagnosis stage (9.5%, p < 0.001), treatment (15.3%, p < 0.001), and optimal care (11.4%, p < 0.001). Neighborhood‐level SES accounted for the third largest proportion of the effects of race on each outcome, explaining between 9% and 16% of the racial inequities at each phase (all p < 0.001).

Conclusions

Individual‐ and neighborhood‐level structural factors partly explain inequities in NSCLC care, and their effects vary based on the phase of care. Interventions should be adapted to the phase of care.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Black or African AmericanCarcinoma, Non-Small-Cell LungHealthcare DisparitiesLung NeoplasmsAgedAged, 80 and overFemaleHumansMaleMedicareRacismSEER ProgramUnited StatesWhite

Stichwörter der Autor:innen

mediation analysisnon‐small cell lung cancerquality of careracial inequitiesstructural racism

Autor:innen und Institutionen

  • Department of Surgery, Yale School of Medicine, New Haven, Connecticut, USA.
  • Yale National Clinician Scholars Program, New Haven, Connecticut, USA.
  • Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, Yale Cancer Center, New Haven, Connecticut, USA.
  • Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
  • Department of Radiation Oncology, St. Francis Hospital and Trinity Health of New England, Hartford, Connecticut, USA.
  • Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.

ORCID-Profile: Safraz A Hamid, Craig E Pollack, Lorraine T Dean, Maureen E Canavan, Cary P Gross

Förderung

  • NIMHD NIH HHS
  • NCATS NIH HHS
  • NCI NIH HHS
  • National Cancer Institute

Zitieren

APA

Hamid, S. A., Lee, D. H., Herrin, J., Yu, J. B., Pollack, C. E., Dean, L. T., Gaddy, J. J., Oladele, C. R., Feder, S. L., Canavan, M. E., Nunez-Smith, M., Soulos, P. R., & Gross, C. P. (2025). Mediators of Racial Inequities in Non‐Small Cell Lung Cancer Care. Cancer Medicine, 14(5). https://doi.org/10.1002/cam4.70757

Vancouver

Hamid SA, Lee DH, Herrin J, Yu JB, Pollack CE, Dean LT, et al. Mediators of Racial Inequities in Non‐Small Cell Lung Cancer Care. Cancer Medicine. 2025;14(5). doi:10.1002/cam4.70757

BibTeX
@article{Hamid2025,
  author = {Hamid, Safraz A and Lee, Do H and Herrin, Jeph and Yu, James B and Pollack, Craig E and Dean, Lorraine T and Gaddy, Jacquelyne J and Oladele, Carol R and Feder, Shelli L and Canavan, Maureen E and Nunez-Smith, Marcella and Soulos, Pamela R and Gross, Cary P},
  title = {Mediators of Racial Inequities in Non‐Small Cell Lung Cancer Care},
  journal = {Cancer Medicine},
  year = {2025},
  volume = {14},
  number = {5},
  doi = {10.1002/cam4.70757}
}
Kostenlos starten →